Keyphrases
Intravitreal Ranibizumab
100%
Open Globe Injury
100%
Intravitreal Triamcinolone Acetonide Injection
100%
Triamcinolone Acetonide
44%
Bevacizumab
33%
Overexpression
22%
Rabbit Eye
22%
Intravitreal Injection
22%
Intraocular Pressure
22%
Pro-inflammatory Proteins
22%
High Risk
11%
Positive Control
11%
3-group
11%
Tukey
11%
Negative Control
11%
Immunohistochemistry
11%
Good Safety
11%
Clinical Examination
11%
Safety Profile
11%
Anterior Segment
11%
Left Eye
11%
Ocular Lesions
11%
Multiple Comparison Tests
11%
Decapitation
11%
Posterior Segment
11%
Retinal Detachment
11%
Intravitreal
11%
Limbus
11%
Medicine and Dentistry
Triamcinolone Acetonide
100%
Bevacizumab
100%
Tumor Necrosis Factor
60%
Vasculotropin
60%
Intraocular Pressure
40%
Intravitreal Administration
40%
Immunohistochemistry
20%
Clinical Examination
20%
Downregulation
20%
Eye Injury
20%
Retinal Detachment
20%
Decapitation
20%
Corneal Limbus
20%
Immunology and Microbiology
Bevacizumab
100%
Triamcinolone
100%
Tumor Necrosis Factor
60%
Vasculotropin
60%
Leporidae
40%
Intraocular Pressure
40%
Downregulation
20%
Decapitation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
100%
Triamcinolone Acetonide
100%
Tumor Necrosis Factor
60%
Vasculotropin
60%
Leporidae
40%
Intravitreal Administration
40%
Eye Injury
20%
Retina Detachment
20%
Neuroscience
Triamcinolone Acetonide
100%
Bevacizumab
100%
Vascular Endothelial Growth Factor
60%
Intraocular Pressure
40%
Immunohistochemistry
20%
Retinal Detachment
20%